VEGFR2/VEGF-A ligand binding decreased ranibizumab and aflibercept mediated CCL2, CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)

Magnetic resonance imaging (MRI) of liver, heart, lumbar spine, and iliac crest at baseline and at the end of follow-up. by Lucas L. A. Nunes (19360381)

In primary cultures of differentiated subcutaneous (a) and omental (b) pre-adipocytes, Dex decreases lipogenesis in the absence of insulin. by Laura L. Gathercole (341979)

Acid wash decrease, but do not attenuate sCT mediated prolonged cAMP and β-arrestin signaling. by Kim Vietz Andreassen (317792)

Acquisition of Mutant scFv With a Higher Affinity against Wild-type, Beta and Delta SARS-CoV-2 using a HEK 293T Antibody Surface Display Library. by Ye Yang (297214)

SHIP-1 PRD region is necessary and sufficient to decrease NOD2-induced NF-κB activity. by Claude Condé (150801)

Comparative experiment of different YOLOv5 versions. by Zhongjian Xie (4633099)

Exposure to EtBr decreases mtRNA in rat striatal co-cultures, purified neuronal cultures, and astrocytes. by Emily Booth Warren (4276333)

“…Error bars reflect delta-method propagated +/-SEM, with level of significance determined following Dunn’s post-hoc test. 2D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref005" target="_blank">5</a>] = 5ng/ml EtBr for 2 days, 4D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref005" target="_blank">5</a>] = 5ng/ml EtBr for 4 days, 2D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref050" target="_blank">50</a>] = 50ng/ml EtBr for 2 days, 4D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref050" target="_blank">50</a>] = 50ng/ml EtBr for 4 days. …”

Identification of novel, small molecule TTBK1 inhibitor which dose dependently decreases tau phosphorylation at S422. by Gregory M. Dillon (8681430)

Inhibition of Hsp90 abolished VEGF-mediated eNOS phosphorylation and decreased NO production and cell viability in BAECs. by Yuanzhuo Chen (802891)

Rapamycin decreases neoblast proliferation and increases the survival rate in <i>Smed-smg-1</i> RNAi animals. by Cristina González-Estévez (175872)

Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ_m decrease. by Martina Bielaszewska (79970)

“…<p>(<b>A, B</b>) HBMEC (<b>A</b>) and Caco-2 cells (<b>B</b>) were incubated for the times indicated with EHEC-Hly-containing OMVs TA50 or 8033 (20 µg of OMV protein containing 100 ng of EHEC-Hly) or with corresponding protein amounts of EHEC-Hly-negative OMVs TA51 or 8033c or left untreated (control). …”

Imatinib or masitinib decreases cell surface expression of mature c-Kit in UT-7/Epo cell line. by Diane D'allard (405441)

The means pre-death food intake of all participants and each 4 groups for 24 weeks to death (Range 1-10). by Sakiko Fukui (387048)

Subjects:

Expression of CavY14F mutant decreases IGF-IR internalization in IGF1 stimulated cells. by Barbara Salani (359372)

Silencing of Rap1A decreases ERK and p38 activation. by Yougen Wu (830191)

Exposure to PBDE47 decreased TNFɑ but not IL1ß methylation status of peripheral blood mononuclear cells. by Tyna Dao (799899)

ETHE1-p.Arg163Gln and p.Arg163Trp are folded but have decreased stability. by Bárbara J. Henriques (627180)

CK1δ-specific kinase activity in HT1080 cells is decreased after activation of Chk1. by Joachim Bischof (189845)

eNOS phosphorylation increased intracellular ROS generation and decreased cell viability in BH4-depleted cells. by Hu Peng (396074)

“…HEK293 eNOS control, *, <i>p</i> < 0.01). 50ng/mL VEGF caused further decrease of cell viability in eNOS overexpressing HEK293 cells treated with 10mM DAHP (VEGF plus DAHP vs. …”